The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Towards organ preservation and cure via 2 infusions of immunotherapy only, in patients normally undergoing extensive and mutilating curative surgery for cutaneous squamous cell carcinoma: An investigator-initiated randomized phase II trial—The MATISSE trial.
 
Charlotte L. Zuur
Consulting or Advisory Role - Achilles Therapeutics; Sanofi
Research Funding - Bristol Myers Squibb Foundation
 
Sabine Breukers
Research Funding - Bristol-Myers Squibb
 
Mercedes Machuca-Ostos
Research Funding - Bristol-Myers Squibb
 
Thomas Boere
Research Funding - Bristol-Myers Squibb
 
Laura Smit
No Relationships to Disclose
 
J.P. De Boer
No Relationships to Disclose
 
Sten Cornelissen
No Relationships to Disclose
 
Arash Navran
No Relationships to Disclose
 
Winan J. van Houdt
Consulting or Advisory Role - Amgen (Inst); belpharma (Inst); Sanofi/Aventis (Inst)
Speakers' Bureau - Boehringer Ingelheim (Inst); MSD (Inst); Novartis (Inst)
 
Bram Westerink
Employment - AstraZeneca Canada (I)
 
Maurits Wondergem
No Relationships to Disclose
 
Remco de Bree
No Relationships to Disclose
 
Lot A. Devriese
Consulting or Advisory Role - Incyte (Inst); Merck (Inst)
 
Daniela Thommen
Employment - Roche
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - iTEOS Therapeutics
Research Funding - Bristol-Myers Squibb
 
Joleen Traets
No Relationships to Disclose
 
John B. A. G. Haanen
Stock and Other Ownership Interests - Neogene Therapeutics
Consulting or Advisory Role - Achilles Therapeutics (Inst); bioNTech (Inst); Bristol-Myers Squibb (Inst); Immunocore (Inst); Instil Bio (Inst); Iovance Biotherapeutics (Inst); Ipsen (Inst); Molecular Partners (Inst); MSD Oncology (Inst); Neogene Therapeutics; Novartis (Inst); Pfizer (Inst); POEM Health (Inst); Roche/Genentech (Inst); Sanofi (Inst); T-Knife (Inst); Third Rock Ventures (Inst)
Research Funding - Amgen (Inst); Asher Biotherapeutics (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Neon Therapeutics (Inst); Novartis (Inst)